Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$17.63 - $21.74 $1.31 Million - $1.62 Million
-74,301 Reduced 10.29%
648,087 $12.8 Million
Q4 2023

Feb 14, 2024

BUY
$14.37 - $19.07 $2.7 Million - $3.59 Million
188,174 Added 35.22%
722,388 $12.7 Million
Q3 2023

Nov 14, 2023

SELL
$13.62 - $20.2 $30,168 - $44,743
-2,215 Reduced 0.41%
534,214 $9.28 Million
Q2 2023

Aug 14, 2023

SELL
$10.44 - $16.48 $402,054 - $634,661
-38,511 Reduced 6.7%
536,429 $7.55 Million
Q1 2023

May 15, 2023

BUY
$10.7 - $15.79 $756,992 - $1.12 Million
70,747 Added 14.03%
574,940 $6.19 Million
Q4 2022

Feb 14, 2023

SELL
$11.42 - $17.05 $549,952 - $821,076
-48,157 Reduced 8.72%
504,193 $7.55 Million
Q3 2022

Nov 14, 2022

BUY
$9.76 - $13.41 $1.29 Million - $1.77 Million
132,355 Added 31.51%
552,350 $7.09 Million
Q2 2022

Aug 15, 2022

SELL
$7.6 - $11.41 $2.45 Million - $3.68 Million
-322,163 Reduced 43.41%
419,995 $4.07 Million
Q1 2022

May 16, 2022

BUY
$9.3 - $12.37 $1.33 Million - $1.76 Million
142,636 Added 23.79%
742,158 $7.38 Million
Q4 2021

Feb 14, 2022

BUY
$10.39 - $15.15 $2.01 Million - $2.93 Million
193,688 Added 47.73%
599,522 $7.06 Million
Q3 2021

Nov 15, 2021

BUY
$11.39 - $16.23 $4.62 Million - $6.59 Million
405,834 New
405,834 $4.62 Million

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Granahan Investment Management, LLC Portfolio

Follow Granahan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.